News

EvoEndo Introduces Additional Gastroscope for Sedation-Free TNE

—New Model LE 85 Single-Use Gastroscope added to the EvoEndo Endoscopy System —

A New Sedation-Free Procedure Helps Doctors Diagnose Upper GI Tract Problems

Weill Cornell Medicine is now offering sedation-free TNE procedure using the EvoEndo Endoscopy System! Their specialists are now using this procedure to diagnose eosinophilic esophagitis (EoE) and...

Expanding Access to Sedation-Free TNE with the EvoEndo® Endoscopy System

—Creating access to novel technology and improved care for every child—

Recent Research Supports Sedation-Free TNE for Effective Management of GI Disorders Utilizing the EvoEndo System

—Sedation-Free TNE is an effective, preferred alternative—

Dr. Matthew Ryan Reaches Milestone 100+ TNEs with the EvoEndo Endoscopy System

Dr. Ryan is the first in the nation to complete over 100 TNEs using the EvoEndo System Philadelphia, PA,February 14, 2024 — EvoEndo®, Inc. (“EvoEndo”), announces that Matthew J. Ryan, MD,...

EvoEndo Elects David Pierce to the Board of Directors

DENVER, CO May 3, 2023 — EvoEndo®, Inc. (“EvoEndo”), a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), is proud to announce that David Pierce has joined our...

Children’s Hospital Los Angeles is the First in California to Use the EvoEndo® System for Unsedated Pediatric Endoscopy

DENVER, CO April 18, 2023 — EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for unsedated Transnasal Endoscopy (TNE), is pleased to announce that Children’s Hospital Los...

EvoEndo Announces Investment from AGA’s GI Opportunity Fund

DENVER, CO, April 13, 2023 — EvoEndo®, Inc. (“EvoEndo”), a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), announced that the company received an investment...

EvoEndo Announces Key Leadership Transitions

Jonathan T. Hartmann appointed as President and Chief Executive Officer Ryan Hartman appointed as Chief Operating Officer DENVER, CO, April 6, 2023 – EvoEndo®, Inc. (“EvoEndo” or the “Company”), a...

EvoEndo® Announces Ambulatory Payment Classification (APC) Reassignments for Flexible Transnasal Esophagogastroduodenoscopy (EGD)

DENVER, CO, EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE), is pleased to share recent decisions announced by the Centers for...